Literature DB >> 11189328

Exon-by-exon screening for RB germline mutations using Heteroduplex-SSCP analysis.

Q Zhang1, K Minoda, R Zeng, Z Wu, X Xiao, S Li, F Zhang.   

Abstract

OBJECTIVE: To disclose the nature of RB1 germline mutations in Chinese and to develop a practical and effective way for mutational screening.
METHODS: Leukocyte DNA was prepared from 8 Chinese patients with hereditary retinoblastoma. PCR combined with nonisotopic heteroduplex-SSCP analysis was used to screen leukocyte DNA for RB1 germline mutations, exon-by-exon, without the use of restriction endonuclease digestion. The mutations were finally identified by sequencing. In order to testify the effectiveness of this method, the same method was used to detect other 17 samples which have been previously analyzed by other methods.
RESULTS: Heterozygous germline mutations were detected in the leukocyte DNA of 6 out of 8 Chinese patients: G del/codon 46, T del/codon 131, CAGAA del/codon 257-258, GCAgta-->GCAgca/donor of exon 16, C-->T/codon 661, and C-->T/codon 787. Heteroduplex-SSCP analysis may detect RB1 germline mutations in 68% (17/25) unselected patients, which is more effective than SSCP(56%) or heteroduplex analysis(64%) alone. The corrected RB1 mutation detection rate may be 80% if the samples were previously analyzed by Southern blotting, which is much higher than those reported on literature.
CONCLUSION: Mutations involving a few base pairs in RB1 gene are common in Chinese. Heteroduplex-SSCP analysis is more useful and effective than SSCP or heteroduplex analysis alone for the rapid screening for unknown mutations.

Entities:  

Mesh:

Year:  1997        PMID: 11189328

Source DB:  PubMed          Journal:  Yan Ke Xue Bao        ISSN: 1000-4432


  3 in total

1.  The RB1 Mutation Spectrum and Genetic Management Consultation in Pediatric Patients with Retinoblastoma in Beijing, China.

Authors:  Ying Xie; Xiao-Lin Xu; Wen-Bin Wei
Journal:  Risk Manag Healthc Policy       Date:  2021-08-21

2.  Screening of RB1 gene mutations in Chinese patients with retinoblastoma and preliminary exploration of genotype-phenotype correlations.

Authors:  Ming-yan He; Yu An; Yi-jin Gao; Xiao-wen Qian; Gang Li; Jiang Qian
Journal:  Mol Vis       Date:  2014-04-25       Impact factor: 2.367

3.  Novel GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism.

Authors:  Shaohua Fang; Xiangming Guo; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Qingjiong Zhang
Journal:  Mol Vis       Date:  2008-10-30       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.